00078-0698 Rydapt - CanMED: NDC

Product NDC:

00078-0698

Brand Name:

Rydapt

Generic Name:

RYDAPT

Dosage Form Name:

CAPSULE, LIQUID FILLED

Administration Route:

Oral

Substances:

Name: Midostaurin

Strength: 25.0

Unit: mg/1

Packages:

Code: 00078-0698-02

Description:

Effective Date: April 28, 2017

Discontinued:

Code: 00078-0698-19

Description: 4 CARTON in 1 CARTON (0078-0698-19) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)

Effective Date: April 28, 2017

Discontinued:

Code: 00078-0698-51

Description:

Effective Date: April 28, 2017

Discontinued:

Code: 00078-0698-99

Description: 2 CARTON in 1 CARTON (0078-0698-99) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)

Effective Date: April 28, 2017

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FLT3

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC